These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 20615932)

  • 1. Procedural and declarative memory task performance, and the memory consolidation function of sleep, in recent and abstinent ecstasy/MDMA users.
    Blagrove M; Seddon J; George S; Parrott AC; Stickgold R; Walker MP; Jones KA; Morgan MJ
    J Psychopharmacol; 2011 Apr; 25(4):465-77. PubMed ID: 20615932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational 'Ecstasy' users.
    Parrott AC
    Neurosci Biobehav Rev; 2013 Sep; 37(8):1466-84. PubMed ID: 23660456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction.
    Quednow BB; Jessen F; Kuhn KU; Maier W; Daum I; Wagner M
    J Psychopharmacol; 2006 May; 20(3):373-84. PubMed ID: 16574711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological function in ecstasy users: a study controlling for polydrug use.
    Roiser JP; Rogers RD; Sahakian BJ
    Psychopharmacology (Berl); 2007 Jan; 189(4):505-16. PubMed ID: 16163532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance.
    Parrott AC; Lasky J
    Psychopharmacology (Berl); 1998 Oct; 139(3):261-8. PubMed ID: 9784083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
    Parrott AC
    J Psychopharmacol; 2006 Mar; 20(2):147-63. PubMed ID: 16510474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrete memory impairments in largely pure chronic users of MDMA.
    Wunderli MD; Vonmoos M; Fürst M; Schädelin K; Kraemer T; Baumgartner MR; Seifritz E; Quednow BB
    Eur Neuropsychopharmacol; 2017 Oct; 27(10):987-999. PubMed ID: 28866005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depression, impulsiveness, sleep, and memory in past and present polydrug users of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).
    Taurah L; Chandler C; Sanders G
    Psychopharmacology (Berl); 2014 Feb; 231(4):737-51. PubMed ID: 24114426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced memory skills and increased hair cortisol levels in recent Ecstasy/MDMA users: significant but independent neurocognitive and neurohormonal deficits.
    Downey LA; Sands H; Jones L; Clow A; Evans P; Stalder T; Parrott AC
    Hum Psychopharmacol; 2015 May; 30(3):199-207. PubMed ID: 25900184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?
    Morgan MJ; McFie L; Fleetwood H; Robinson JA
    Psychopharmacology (Berl); 2002 Jan; 159(3):294-303. PubMed ID: 11862362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Memory deficits associated with recreational use of "ecstasy" (MDMA).
    Morgan MJ
    Psychopharmacology (Berl); 1999 Jan; 141(1):30-6. PubMed ID: 9952062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study.
    Schilt T; de Win MM; Koeter M; Jager G; Korf DJ; van den Brink W; Schmand B
    Arch Gen Psychiatry; 2007 Jun; 64(6):728-36. PubMed ID: 17548754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human ecstasy (MDMA) polydrug users have altered brain activation during semantic processing.
    Watkins TJ; Raj V; Lee J; Dietrich MS; Cao A; Blackford JU; Salomon RM; Park S; Benningfield MM; Di Iorio CR; Cowan RL
    Psychopharmacology (Berl); 2013 May; 227(1):41-54. PubMed ID: 23241648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurocognitive function in current and ex-users of ecstasy in comparison to both matched polydrug-using controls and drug-naïve controls.
    Hoshi R; Mullins K; Boundy C; Brignell C; Piccini P; Curran HV
    Psychopharmacology (Berl); 2007 Oct; 194(3):371-9. PubMed ID: 17605005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users.
    Gouzoulis-Mayfrank E; Thimm B; Rezk M; Hensen G; Daumann J
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):819-27. PubMed ID: 12921915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated impulsivity and impaired decision-making cognition in heavy users of MDMA ("Ecstasy").
    Quednow BB; Kühn KU; Hoppe C; Westheide J; Maier W; Daum I; Wagner M
    Psychopharmacology (Berl); 2007 Jan; 189(4):517-30. PubMed ID: 16425060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users.
    Fox HC; McLean A; Turner JJ; Parrott AC; Rogers R; Sahakian BJ
    Psychopharmacology (Berl); 2002 Jul; 162(2):203-14. PubMed ID: 12110998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
    de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
    J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysfunctional overnight memory consolidation in ecstasy users.
    Smithies V; Broadbear J; Verdejo-Garcia A; Conduit R
    J Psychopharmacol; 2014 Aug; 28(8):751-62. PubMed ID: 24595967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.